These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11412858)

  • 1. Protein misfolding and disease; protein refolding and therapy.
    Soto C
    FEBS Lett; 2001 Jun; 498(2-3):204-7. PubMed ID: 11412858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational diseases].
    Gregersen N; Bross P; Bolund LA
    Ugeskr Laeger; 2003 Feb; 165(8):801-5. PubMed ID: 12625122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PABMB Lecture. Protein dynamics, folding and misfolding: from basic physical chemistry to human conformational diseases.
    Ferreira ST; De Felice FG
    FEBS Lett; 2001 Jun; 498(2-3):129-34. PubMed ID: 11412843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein aggregation.
    Merlini G; Bellotti V; Andreola A; Palladini G; Obici L; Casarini S; Perfetti V
    Clin Chem Lab Med; 2001 Nov; 39(11):1065-75. PubMed ID: 11831622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular Pathogenesis of Polyglutamine Diseases].
    Takahashi Y
    Brain Nerve; 2017 Aug; 69(8):901-912. PubMed ID: 28819074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein misfolding, aggregation, and degradation in disease.
    Gregersen N; Bolund L; Bross P
    Mol Biotechnol; 2005 Oct; 31(2):141-50. PubMed ID: 16170215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein misfolding in conformational disorders.
    Gomes CM
    Curr Top Med Chem; 2012; 12(22):2459. PubMed ID: 23339299
    [No Abstract]   [Full Text] [Related]  

  • 9. Unfolded protein ensembles, folding trajectories, and refolding rate prediction.
    Das A; Sin BK; Mohazab AR; Plotkin SS
    J Chem Phys; 2013 Sep; 139(12):121925. PubMed ID: 24089737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurodegenerative conformational disease and its molecular bases].
    Li WW; Cai DF; Ren HM
    Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):97-102. PubMed ID: 16850610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of ligand-induced protein conformational alteration, aggregate formation, and its inhibition: A biophysical insight.
    Nusrat S; Khan RH
    Prep Biochem Biotechnol; 2018 Jan; 48(1):43-56. PubMed ID: 29106330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein folding, misfolding and aggregation: evolving concepts and conformational diseases.
    Ramos CH; Ferreira ST
    Protein Pept Lett; 2005 Apr; 12(3):213-22. PubMed ID: 15777268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the gap: from protein misfolding to protein misfolding diseases.
    Luheshi LM; Dobson CM
    FEBS Lett; 2009 Aug; 583(16):2581-6. PubMed ID: 19545568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases.
    Breydo L; Uversky VN
    Metallomics; 2011 Nov; 3(11):1163-80. PubMed ID: 21869995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-misfolding diseases and chaperone-based therapeutic approaches.
    Chaudhuri TK; Paul S
    FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for misfolding protein diseases of the central nervous system.
    San Sebastian W; Samaranch L; Kells AP; Forsayeth J; Bankiewicz KS
    Neurotherapeutics; 2013 Jul; 10(3):498-510. PubMed ID: 23700209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of protein misfolding and aggregation by small rationally-designed peptides.
    Estrada LD; Soto C
    Curr Pharm Des; 2006; 12(20):2557-67. PubMed ID: 16842178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular aspects of protein misfolding and disease.
    Herczenik E; Gebbink MF
    FASEB J; 2008 Jul; 22(7):2115-33. PubMed ID: 18303094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.